Opendata, web and dolomites

DERMAE

Clinical research for the validation of a non-invasive medical imaging device for dermatological diagnoses

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DERMAE project word cloud

Explore the words cloud of the DERMAE project. It provides you a very rough idea of what is the project "DERMAE" about.

few    slices    tissues    biopsy    producing    entire    constitute    cancers    dermatological    portion    pain    revolutionize    structural    imaging    deformation    misses    skin    patient    freeze    diseases    scarring    patients    images    procedure    excision    40    dermatologists    diagnostic    anomaly    instrument    healthcare    15    announcement    histological    surgical    structures    microscope    innovative    biopsies    benign    painful    pathologies    days    time    issue    dangerous    internal    visually    extra    form    implies    deep    reoperation    millions    consuming    thickness    image    detected    introduce    stress    lesion    tissue    situ    melanoma    resolution    tumor    cut    tool    perform    mu    micrometers    potentially    macroscopic    mm    damages    excise    dermatologist    diagnoses    mainly    60    12    necessitate    consult    dyes    minor    world    performed    solves    diagnosis    biological    surface    symptoms    cellular    histopathological    color    optical    treatment    dermae    medical    awarded    criteria    sections    act    invasive    reception    size    incurs    remove    dermatology    technique   

Project "DERMAE" data sheet

The following table provides information about the project.

Coordinator
DAMAE MEDICAL 

Organization address
address: BATIMENT 503 - CAMPUS SCIENTIFIQUE D'ORSAY
city: ORSAY
postcode: 91400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website http://damaemedical.fr/w/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-04-01   to  2015-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DAMAE MEDICAL FR (ORSAY) coordinator 50˙000.00

Map

 Project objective

Diagnosis and study of many diseases in dermatology, including cancers, mainly depend on biopsy and histopathological analysis of tissue at the cellular-level using an optical microscope. This medical procedure implies to perform a biopsy, i.e. to excise a portion of tissue, then to freeze and cut the sample into slices of a few micrometers thickness and use specific dyes. This procedure is painful and potentially dangerous for the patient. Moreover it is time-consuming and may introduce structural deformation or damages. Skin diseases like Melanoma are rapidly growing throughout the world. About 12 millions biopsies are performed each year by dermatologists. As a minor surgical act, the biopsy process involves pain, possible scarring, and stress during the 15 days before reception of analyses results. In 60% of the cases, the skin anomaly is benign and do not necessitate further treatment. However, the patients need to consult another time with the dermatologist for the announcement of the results of the biopsy, which incurs extra medical costs and time. Moreover, as symptoms are detected on a macroscopic-level with surface criteria (color, form and size of the lesion), the dermatologist misses over one third of the pathologies. Finally, as the tissue excision is visually performed, 40% of reoperation is necessary to remove the entire tumor. DERMAE is a highly recognized and awarded innovative project that solves this major healthcare issue by developing an innovative instrument capable of producing in situ images of biological tissues similar to histological sections. This non- invasive imaging technique will be able to image in real time the internal structures (up to 1 mm deep) of biological tissues at the cellular level (about 1 μm resolution). This imaging technology will constitute a new diagnostic tool that may revolutionize the medical procedures in dermatological diagnoses.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DERMAE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DERMAE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More